Excess mortality in England post COVID-19 pandemic: implications for secondary prevention
- PMID: 38188277
- PMCID: PMC10769885
- DOI: 10.1016/j.lanepe.2023.100802
Excess mortality in England post COVID-19 pandemic: implications for secondary prevention
Conflict of interest statement
JP-S is Partner at Lane Clark & Peacock LLP, Chair of the Royal Society for Public Health and reports personal fees from Novo Nordisk and Pfizer Ltd outside of this submitted work. SM is Partner at Lane Clark & Peacock LLP and deputy Chair of the Continuous Mortality Investigation. All other authors declare no competing interests.
References
-
- Office for National Statistics . 2023. Deaths involving coronavirus (COVID-19) by month of registration.https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarri... UK.
-
- Institute and Faculty of Actuaries . 2023. England & Wales mortality monitor - week 26.https://www.actuaries.org.uk/system/files/field/document/Mortality%20mon...
-
- Dale C.E., Takhar R., Carragher R., et al. The impact of the COVID-19 pandemic on cardiovascular disease prevention and management. Nat Med. 2023;29:219–225. - PubMed
LinkOut - more resources
Full Text Sources